PRK(PRK)
PRK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $691M | $709M |
| Low | $682M | $697M |
| High | $701M | $722M |
| EBITDA Avg | $242M | $248M |
| Low | $239M | $244M |
| High | $245M | $253M |
| EBIT Avg | $227M | $232M |
| Low | $223M | $228M |
| High | $230M | $237M |
| Net Income Avg | $209M | $216M |
| Low | $203M | $207M |
| High | $215M | $225M |
| EPS Avg | $12.98 | $13.23 |
| Low | $12.55 | $12.81 |
| High | $13.30 | $13.92 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $177M | $177M | $175M | $178M | $178M | $179M |
| Low | $174M | $174M | $172M | $175M | $175M | $177M |
| High | $179M | $180M | $178M | $181M | $181M | $182M |
| EBITDA Avg | $62M | $62M | $61M | $62M | $62M | $63M |
| Low | $61M | $61M | $60M | $61M | $61M | $62M |
| High | $63M | $63M | $62M | $63M | $63M | $64M |
| EBIT Avg | $58M | $58M | $57M | $58M | $58M | $59M |
| Low | $57M | $57M | $56M | $57M | $57M | $58M |
| High | $59M | $59M | $58M | $59M | $59M | $60M |
| Net Income Avg | $59M | $59M | $58M | $60M | $59M | $59M |
| Low | $56M | $57M | $57M | $59M | $58M | $58M |
| High | $61M | $62M | $60M | $61M | $60M | $60M |
| EPS Avg | $3.30 | $3.33 | $3.27 | $3.35 | $3.30 | $3.31 |
| Low | $3.15 | $3.21 | $3.21 | $3.29 | $3.24 | $3.25 |
| High | $3.43 | $3.50 | $3.34 | $3.42 | $3.38 | $3.38 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |